GO:0016860 intramolecular oxidoreductase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016860 intramolecular oxidoreductase activity describes catalysis of a redox reaction in which the hydrogen donor and acceptor are the same molecule and no oxidized product appears.
• This activity is central to prostaglandin, hepoxilin, prostacyclin and other eicosanoid biosynthetic reactions, where a single substrate undergoes internal redox rearrangement.
• Enzymes with this activity include prostaglandin E synthases, prostacyclin synthase, hepoxilin A3 synthase and macrophage migration inhibitory factor.
• Because the donor and acceptor are the same molecule, these enzymes often act as isomerases and are mechanistically distinct from classical dehydrogenases.
• Dysregulation of intramolecular oxidoreductase reactions has been linked to inflammation, atherogenesis and carcinogenesis.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools for dissecting the causal roles of these enzymes in disease.
Description
Intramolecular oxidoreductase activity (GO:0016860) is a molecular function defined as catalysis of an oxidation-reduction (redox) reaction in which the hydrogen donor and acceptor are the same molecule, and no oxidized product appears. In practical terms, the enzyme rearranges a substrate internally rather than transferring electrons to an external acceptor, which makes the reaction formally an isomerization coupled to a redox change. This activity is widely represented in eicosanoid biosynthesis, where prostaglandin E synthases, prostacyclin synthase and hepoxilin A3 synthase convert unstable endoperoxide or epoxide intermediates into bioactive lipid mediators. The same catalytic logic also appears in microbial and mammalian redox systems, including organohalide respiratory chains and nitroso-ene-type transformations. For researchers, GO:0016860 provides a precise functional annotation that distinguishes intramolecular redox isomerization from intermolecular oxidoreductase reactions, and it is therefore a useful entry point for studying lipid signaling, inflammation and redox biology. Because the donor and acceptor are the same molecule, these enzymes often function without a separate oxidized product, which has important implications for pathway flux and for the design of inhibitors.
intramolecular oxidoreductase activity At A Glance
| GO ID | GO:0016860 |
|---|---|
| GO term | intramolecular oxidoreductase activity |
| Ontology | molecular_function |
| Synonym | intramolecular isomerase activity; intramolecular oxidoreductase activity; other intramolecular oxidoreductases |
| Definition | Catalysis of an oxidation-reduction (redox) reaction in which the hydrogen donor and acceptor are the same molecule, and no oxidized product appears. |
| Major function | Internal redox rearrangement of a single substrate, often converting an endoperoxide or epoxide into a bioactive product. |
| Representative enzymes | Prostaglandin E synthases, prostacyclin synthase, hepoxilin A3 synthase, macrophage migration inhibitory factor. |
| Biological context | Eicosanoid biosynthesis, inflammation, redox regulation, microbial organohalide respiration. |
| Research relevance | Target for anti-inflammatory and anti-cancer studies; functional annotation in genome and metagenome analysis. |
What Is GO:0016860?
GO:0016860 intramolecular oxidoreductase activity is a molecular function term describing catalysis of an oxidation-reduction reaction in which the hydrogen donor and acceptor are the same molecule, and no oxidized product appears. The reaction is therefore an internal redox rearrangement, often described as an intramolecular isomerase activity. It is distinct from oxidoreductases that transfer electrons between different molecules, because the substrate itself supplies both the reducing and oxidizing equivalents.
Why Is intramolecular oxidoreductase activity Important in Cell Biology?
GO:0016860 is important because it defines a mechanistically distinctive class of redox enzymes that shape lipid mediator production and cellular redox balance. Prostaglandin E synthases, prostacyclin synthase and hepoxilin A3 synthase are directly involved in inflammation, vascular biology and carcinogenesis, and their catalytic activity fits the intramolecular oxidoreductase definition. Macrophage migration inhibitory factor has been linked to cellular redox regulation, further connecting this activity to stress responses. In addition, oxidative alterations of cyclooxygenase during atherogenesis illustrate how redox chemistry in eicosanoid pathways contributes to disease. Because the donor and acceptor are the same molecule, these enzymes can be targeted without the confounding effects of external electron acceptors, making them attractive for mechanistic and pharmacological studies.
• Defines a unique redox mechanism in which a single substrate acts as both hydrogen donor and acceptor.
• Underpins biosynthesis of prostaglandin E2, prostacyclin and hepoxilin A3, key lipid mediators.
• Connects redox chemistry to inflammation and atherogenesis through eicosanoid pathway enzymes.
• Provides functional annotation for enzymes in microbial organohalide respiratory chains.
• Includes enzymes capable of nitroso-ene-type C-N bond formation, expanding its mechanistic scope.
• Links macrophage migration inhibitory factor to cellular redox regulation.
• Supports anti-inflammatory and anti-cancer target discovery in prostaglandin and prostacyclin pathways.
• Enables comparative genomics and metagenomics by distinguishing intramolecular from intermolecular oxidoreductases.
• Facilitates CRISPR-based causal validation of lipid mediator enzymes in disease models.
• Guides inhibitor design by focusing on internal redox rearrangement rather than external electron transfer.
Molecular Mechanism of intramolecular oxidoreductase activity
Substrate binding and internal redox rearrangement
In simple terms: The enzyme grabs a single molecule and rearranges its internal electrons.
In intramolecular oxidoreductase reactions, the substrate itself provides both the hydrogen donor and acceptor. Enzymes such as prostaglandin E synthases and prostacyclin synthase bind endoperoxide intermediates and catalyze internal redox rearrangements that yield bioactive prostaglandins or prostacyclin. Because no external oxidized product is released, the reaction is effectively an isomerization coupled to a redox change, which distinguishes GO:0016860 from classical dehydrogenases.
Endoperoxide and epoxide conversions
In simple terms: Unstable oxygen-containing rings are converted into stable signaling molecules.
Hepoxilin A3 synthase acts on epoxide intermediates to generate hepoxilins, a reaction that fits the intramolecular oxidoreductase definition because the substrate undergoes internal redox rearrangement. Similarly, prostaglandin E synthases convert prostaglandin H2 into prostaglandin E2 through an intramolecular redox process. These conversions are central to eicosanoid signaling and are often rate-limiting for inflammatory mediator production.
Cofactors and redox chemistry
In simple terms: Some of these enzymes use special chemical groups to move electrons internally.
Although the donor and acceptor are the same molecule, many intramolecular oxidoreductases still require cofactors or metal centers to stabilize the transition state. Macrophage migration inhibitory factor has been linked to cellular redox regulation, indicating that redox-active residues or cofactors can participate in these reactions. Oxidative alterations of cyclooxygenase during atherogenesis further show that redox chemistry in eicosanoid pathways is sensitive to the cellular environment.
Microbial and non-eicosanoid examples
In simple terms: The same reaction logic appears in bacteria and in unusual bond-forming chemistry.
Organohalide respiratory chains in bacteria use key enzymes that catalyze internal redox transformations as part of energy metabolism. In addition, aerobic C-N bond formation through enzymatic nitroso-ene-type reactions demonstrates that intramolecular redox chemistry can support novel bond construction. These examples broaden the biological scope of GO:0016860 beyond mammalian lipid signaling.
Regulation by substrate availability and redox state
In simple terms: How much substrate is around and how oxidized the cell is can control these enzymes.
Because the substrate supplies both redox equivalents, the flux through intramolecular oxidoreductase reactions depends strongly on substrate availability and the local redox environment. In eicosanoid pathways, upstream cyclooxygenase activity and oxidative stress can alter the supply of endoperoxide intermediates. Macrophage migration inhibitory factor provides an example of how redox regulation can be integrated with inflammatory signaling.
Key Genes Involved in GO:0016860 intramolecular oxidoreductase activity
The following genes and proteins are representative of intramolecular oxidoreductase activity (GO:0016860) and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTGES | Prostaglandin E synthase; converts prostaglandin H2 to prostaglandin E2 | Inflammation and cancer studies |
| PTGES2 | Prostaglandin E synthase 2; intramolecular redox conversion of endoperoxides | Eicosanoid pathway research |
| PTGES3 | Cytosolic prostaglandin E synthase; produces prostaglandin E2 | Inflammatory mediator studies |
| PTGIS | Prostacyclin synthase; catalyzes prostacyclin formation | Vascular biology and carcinogenesis |
| ALOX12 | Lipoxygenase; upstream of hepoxilin synthesis | Hepoxilin A3 synthase pathway |
| ALOX15 | Lipoxygenase; contributes to eicosanoid intermediates | Inflammation and redox studies |
| MIF | Macrophage migration inhibitory factor; linked to cellular redox regulation | Redox and inflammation research |
| PTGS1 | Cyclooxygenase 1; upstream of endoperoxide substrates | Atherogenesis and eicosanoid studies |
| PTGS2 | Cyclooxygenase 2; inducible upstream enzyme | Inflammation and cancer models |
| CBR1 | Carbonyl reductase; redox metabolism of prostaglandins | Eicosanoid metabolism |
| AKR1C3 | Aldo-keto reductase; prostaglandin metabolism | Lipid mediator research |
| HPGD | 15-hydroxyprostaglandin dehydrogenase; prostaglandin catabolism | Inflammation resolution |
| GPX1 | Glutathione peroxidase; redox balance | Cellular redox regulation |
| TXN | Thioredoxin; redox control | Redox biology |
| NQO1 | Quinone oxidoreductase; redox metabolism | Oxidative stress studies |
| CYP2J2 | Cytochrome P450; epoxyeicosatrienoic acid formation | Eicosanoid research |
| EPHX2 | Soluble epoxide hydrolase; epoxide metabolism | Lipid mediator pathways |
How Is intramolecular oxidoreductase activity Regulated?
Intramolecular oxidoreductase activity is regulated primarily by substrate availability, redox state and upstream enzyme expression. In eicosanoid pathways, cyclooxygenase enzymes supply endoperoxide substrates, and oxidative stress can alter their activity during atherogenesis. Macrophage migration inhibitory factor is linked to cellular redox regulation, suggesting that redox-sensitive signaling can modulate this activity. Because the donor and acceptor are the same molecule, regulation often occurs at the level of substrate supply rather than through external electron carriers.
intramolecular oxidoreductase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTGES | Inflammation and cancer | Knockout and overexpression cell models |
| PTGIS | Carcinogenesis and vascular disease | Point-mutation and knockout models |
| MIF | Redox regulation and inflammation | Knockout and tagged knock-in models |
| PTGS2 | Atherogenesis and inflammation | Overexpression and knockout models |
| ALOX12 | Hepoxilin-mediated inflammation | Knock-in and point-mutation models |
Inflammation and eicosanoid signaling
Intramolecular oxidoreductase reactions are central to the production of prostaglandin E2 and other inflammatory mediators. Prostaglandin E synthases convert prostaglandin H2 into prostaglandin E2 through an internal redox rearrangement, and perturbing the arachidonic acid metabolic network can control inflammation. Hepoxilin A3 synthase generates hepoxilins that contribute to inflammatory signaling.
Cancer and prostacyclin biology
Prostacyclin synthase (PTGIS) has been studied for its role in carcinogenesis, where altered prostacyclin production can influence tumor progression and vascular biology. Because prostacyclin synthase catalyzes an intramolecular oxidoreductase reaction, its activity is directly relevant to cancer research.
Atherogenesis and oxidative stress
Oxidative alterations of cyclooxygenase during atherogenesis demonstrate that redox changes in eicosanoid pathways contribute to vascular disease. Macrophage migration inhibitory factor has been linked to cellular redox regulation, further connecting intramolecular redox chemistry to inflammatory and vascular pathology.
Microbial and environmental biology
Organohalide respiratory chains use key enzymes that catalyze internal redox transformations, and these systems are important for bioremediation and microbial ecology. Enzymatic nitroso-ene-type reactions also illustrate the broader catalytic potential of intramolecular redox chemistry.
From intramolecular oxidoreductase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTGES reduce prostaglandin E2 production? | PTGES knockout cell line |
| Does a catalytic residue mutation abolish intramolecular oxidoreductase activity? | Point-mutation knock-in of PTGIS |
| Can tagged PTGES be used to monitor substrate flux? | Tagged knock-in of PTGES |
| Does overexpression of MIF alter cellular redox state? | MIF overexpression cell model |
| Does PTGS2 overexpression promote atherogenic redox changes? | PTGS2 overexpression model |
| Can hepoxilin A3 synthase activity be abrogated by CRISPR? | ALOX12 knockout model |
How to Study the intramolecular oxidoreductase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of enzyme function | Testing requirement for prostaglandin production |
| Point mutation | Catalytic residue function | Distinguishing redox catalysis from binding |
| Lipidomics | Prostaglandin and hepoxilin levels | Pathway output measurement |
| Redox probes | Cellular redox state | Linking MIF to redox regulation |
| RNA-seq | Transcriptional changes | Pathway remodeling after editing |
| Proteomics | Protein abundance and modifications | Detecting oxidative alterations |
| Tagged knock-in | Protein localization and interactions | Tracking enzyme dynamics |
| Overexpression | Gain-of-function effects | Modeling disease-associated upregulation |
CRISPR knockout and point-mutation screens
CRISPR knockout and point-mutation approaches allow researchers to test whether specific residues are required for intramolecular oxidoreductase activity. For example, mutating catalytic residues in prostaglandin E synthases or prostacyclin synthase can distinguish redox catalysis from substrate binding.
Lipid mediator profiling
Mass spectrometry-based lipidomics can quantify prostaglandin E2, prostacyclin and hepoxilin A3 production in cells with edited intramolecular oxidoreductase genes. This approach directly measures pathway output and complements genetic perturbation.
Redox and oxidative stress assays
Redox-sensitive probes and glutathione measurements can assess how intramolecular oxidoreductase enzymes influence cellular redox balance. Macrophage migration inhibitory factor studies provide a template for linking redox regulation to inflammatory signaling.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal how loss or gain of intramolecular oxidoreductase activity reshapes eicosanoid pathway gene expression. Such datasets help identify compensatory pathways and candidate disease mechanisms.
How CRISPR Can Be Used to Study GO:0016860 intramolecular oxidoreductase activity
Knockout
CRISPR knockout of genes encoding intramolecular oxidoreductases, such as PTGES or PTGIS, can abolish specific lipid mediator production and reveal their contribution to inflammation or cancer. Knockout models are essential for causal inference in eicosanoid biology.
Point Mutation
Point mutations in catalytic residues can separate intramolecular oxidoreductase activity from other functions. For example, mutating key residues in prostaglandin E synthase or prostacyclin synthase can test whether redox catalysis is required for substrate conversion.
Knock-in
Knock-in of tagged or reporter alleles allows real-time monitoring of intramolecular oxidoreductase expression and localization. Tagged PTGES or MIF knock-in models can be used to track enzyme dynamics during inflammatory responses.
Overexpression
Overexpression of intramolecular oxidoreductase genes can model disease-associated upregulation. For example, PTGS2 or MIF overexpression can mimic oxidative and inflammatory states observed in atherogenesis.
How EDITGENE Supports intramolecular oxidoreductase activity Research
Researchers studying intramolecular oxidoreductase activity-related genes often need to determine whether a candidate gene is causally involved in lipid mediator production, redox regulation or disease progression. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of these enzymes.
Contact EDITGENE today to design your custom CRISPR model for intramolecular oxidoreductase activity research.
Frequently Asked Questions About intramolecular oxidoreductase activity
What is intramolecular oxidoreductase activity?
It is a molecular function (GO:0016860) that catalyzes a redox reaction in which the hydrogen donor and acceptor are the same molecule, and no oxidized product appears.
What genes are involved in intramolecular oxidoreductase activity?
Representative genes include PTGES, PTGES2, PTGES3, PTGIS, ALOX12 and MIF, which participate in eicosanoid and redox pathways.
What is the GO ID for intramolecular oxidoreductase activity?
The GO ID is GO:0016860.
How is intramolecular oxidoreductase activity different from other oxidoreductases?
In this activity the donor and acceptor are the same molecule, so the reaction is an internal redox rearrangement rather than an intermolecular electron transfer.
Which diseases are linked to intramolecular oxidoreductase activity?
It has been linked to inflammation, atherogenesis and carcinogenesis through prostaglandin, prostacyclin and hepoxilin pathways.
What is the role of prostaglandin E synthase in this activity?
Prostaglandin E synthases convert prostaglandin H2 to prostaglandin E2 through an intramolecular redox reaction.
How can CRISPR be used to study intramolecular oxidoreductase activity?
CRISPR knockout, point mutation, knock-in and overexpression can test the causal role of enzymes such as PTGES, PTGIS and MIF in disease models.
What methods measure intramolecular oxidoreductase activity?
Lipidomics, redox probes, RNA-seq, proteomics and tagged knock-in models are commonly used to measure pathway output and enzyme dynamics.
Is prostacyclin synthase an intramolecular oxidoreductase?
Yes, prostacyclin synthase catalyzes prostacyclin formation through an internal redox reaction and has been studied in carcinogenesis.
What is the clinical relevance of intramolecular oxidoreductase activity?
It is relevant to anti-inflammatory and anti-cancer strategies because these enzymes control bioactive lipid mediator production.
Conclusion
GO:0016860 intramolecular oxidoreductase activity defines a mechanistically distinct class of redox enzymes in which a single substrate acts as both hydrogen donor and acceptor. This activity is central to eicosanoid biosynthesis, redox regulation and microbial metabolism, with representative enzymes including prostaglandin E synthases, prostacyclin synthase, hepoxilin A3 synthase and macrophage migration inhibitory factor. Dysregulation of these enzymes has been linked to inflammation, atherogenesis and carcinogenesis. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide powerful tools to dissect the causal roles of these enzymes and to identify new therapeutic opportunities.
References
- 1. Meng H et al.. 2015. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.. Acc Chem Res 48(8):2242-50 PMID: 26237215
- 2. Nakatani Y et al.. 2002. [Prostaglandin E2 synthases].. Nihon Yakurigaku Zasshi 120(6):373-8 PMID: 12528468
- 3. Nigam S et al.. 2005. Hepoxilin A3 synthase.. Biochem Biophys Res Commun 338(1):161-8 PMID: 16198304
- 4. Sasaki Y et al.. 2017. Role of prostacyclin synthase in carcinogenesis.. Prostaglandins Other Lipid Mediat 133:49-52 PMID: 28506876
- 5. Schubert T et al.. 2018. Organohalide respiratory chains: composition, topology and key enzymes.. FEMS Microbiol Ecol 94(4) PMID: 29718172
- 6. Jäger C et al.. 2023. Aerobic C-N Bond Formation through Enzymatic Nitroso-Ene-Type Reactions.. Angew Chem Int Ed Engl 62(7):e202213671 PMID: 36468873
- 7. Upmacis RK et al.. 2006. Oxidative alterations of cyclooxygenase during atherogenesis.. Prostaglandins Other Lipid Mediat 80(1-2):1-14 PMID: 16846782
- 8. Thiele M et al.. 2005. Link between macrophage migration inhibitory factor and cellular redox regulation.. Antioxid Redox Signal 7(9-10):1234-48 PMID: 16115028
